by Rutgers University Graphical abstract. Credit: Cell Reports Methods (2022). DOI: 10.1016/j.crmeth.2022.100287 Rutgers scientists have developed a new approach to stopping viral infections: a so-called live-attenuated, replication-defective DNA virus vaccine that uses a compound known as centanamycin to generate an altered virus for vaccine development. The method was tested to produce a weakened or “attenuated” version of...
